tert-butylhydroperoxide has been researched along with methyleugenol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Li, S; Liu, Y; Ma, X; Song, Y; Yao, L; Zhou, J | 1 |
1 other study(ies) available for tert-butylhydroperoxide and methyleugenol
| Article | Year |
|---|---|
Methyleugenol protects against t-BHP-triggered oxidative injury by induction of Nrf2 dependent on AMPK/GSK3β and ERK activation.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Survival; Cytoprotection; Eugenol; Extracellular Signal-Regulated MAP Kinases; Glutathione; Glycogen Synthase Kinase 3 beta; MAP Kinase Signaling System; Mice; NF-E2-Related Factor 2; Oxidative Stress; Protective Agents; RAW 264.7 Cells; Reactive Oxygen Species; Superoxide Dismutase; tert-Butylhydroperoxide; Up-Regulation | 2017 |